MAPT and early-onset autosomal dominant Alzheimer disease: In the meantime, the OGA inhibitor Thiamet G is currently showing promise to alter tau protein hyperphosphorylation in animal models of Alzheimer's disease 166 and may work to help sensitize human leukemia cell lines to chemotherapy 167.